{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:18:14Z","timestamp":1790061494028,"version":"4.0.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000055","name":"NIDCD","doi-asserted-by":"publisher","award":["DC000079"],"award-info":[{"award-number":["DC000079"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000055","name":"NIDCD","doi-asserted-by":"publisher","award":["DC000080"],"award-info":[{"award-number":["DC000080"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hearing Research"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.heares.2019.02.006","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T18:03:47Z","timestamp":1550858627000},"page":"66-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity"],"prefix":"10.1016","volume":"375","author":[{"given":"K.","family":"Fernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Wafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.S.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.L.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.heares.2019.02.006_bib1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.mph.0000141348.62532.73","article-title":"Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss","volume":"26","author":"Bertolini","year":"2004","journal-title":"J.\u00a0Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.heares.2019.02.006_bib2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.heares.2013.09.003","article-title":"Age-related hearing loss patterns in Fischer 344\/NHsd rats with cisplatin-induced hearing loss","volume":"306","author":"Bielefeld","year":"2013","journal-title":"Hear. Res."},{"issue":"1","key":"10.1016\/j.heares.2019.02.006_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1006\/mthe.2002.0627","article-title":"Neurotrophin-3 transduction attenuates cisplatin spiral ganglion neuron ototoxicity in the cochlea","volume":"6","author":"Bowers","year":"2002","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.heares.2019.02.006_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-01837-1","article-title":"Cisplatin is retained in the cochlea indefinitely following chemotherapy","volume":"8","author":"Breglio","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heares.2019.02.006_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1472-6904-8-7","article-title":"Long-term platinum retention after treatment with cisplatin and oxaliplatin","volume":"8","author":"Brouwers","year":"2008","journal-title":"BMC Clin. Pharmacol."},{"key":"10.1016\/j.heares.2019.02.006_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuro.2017.02.007","article-title":"Dose-dependent cochlear and vestibular toxicity of transtympanic cisplatin in rat","volume":"60","author":"Callejo","year":"2017","journal-title":"Neurotoxicology (Little Rock)"},{"key":"10.1016\/j.heares.2019.02.006_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/MPH.0b013e318059c220","article-title":"Ototoxicity from cisplatin therapy in childhood cancer","volume":"29","author":"Coradini","year":"2007","journal-title":"J.\u00a0Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.heares.2019.02.006_bib8","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/ar.22577","article-title":"Review: ototoxic characteristics of platinum antitumor drugs","volume":"295","author":"Ding","year":"2012","journal-title":"Anat. Rec."},{"key":"10.1016\/j.heares.2019.02.006_bib9","series-title":"ImageJ Plugin for Cochlear Frequency Mapping in Whole Mounts","author":"Eaton Peabody Laboratories","year":"2018"},{"key":"10.1016\/j.heares.2019.02.006_bib10","series-title":"Tutorial for Cochlear Dissection. Vimeo, Uploaded by Massachusetts Eye and Ear Infirmary","author":"Eaton Peabody Laboratories","year":"2018"},{"key":"10.1016\/j.heares.2019.02.006_bib11","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3109\/14992027.2010.485595","article-title":"Long term hearing degeneration after platinum-based chemotherapy in childhood","volume":"49","author":"Einarsson","year":"2010","journal-title":"Int. J. Audit."},{"issue":"23","key":"10.1016\/j.heares.2019.02.006_bib12","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1200\/JCO.2016.66.8822","article-title":"Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer","volume":"34","author":"Frisina","year":"2016","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.heares.2019.02.006_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0378-5955(90)90046-R","article-title":"Interaction of cisplatin and noise on the peripheral auditory system","volume":"50","author":"Gratton","year":"1990","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2019.02.006_bib14","doi-asserted-by":"crossref","first-page":"7700","DOI":"10.1021\/acs.jmedchem.8b00669","article-title":"Development of second-generation CDK2 inhibitors for the prevention of cisplatin-induced hearing loss","volume":"61","author":"Hazlitt","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"issue":"12","key":"10.1016\/j.heares.2019.02.006_bib15","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.3109\/00016480902856604","article-title":"Effectiveness of different approaches for establishing cisplatin-induced cochlear lesions in mice","volume":"129","author":"He","year":"2009","journal-title":"Acta Otolaryngol."},{"issue":"1","key":"10.1016\/j.heares.2019.02.006_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jnci\/djn418","article-title":"Cisplatin and Oxaliplatin Toxicity: importance of cochlear kinetics as a determinant for ototoxicity","volume":"101","author":"Hellberg","year":"2009","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.heares.2019.02.006_bib17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3109\/15563657808988252","article-title":"Cis-platinum ototoxicity","volume":"13","author":"Helson","year":"1978","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.heares.2019.02.006_bib18","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/MAO.0b013e31818599d5","article-title":"Cisplatin-induced ototoxicity: effect of intratympanic dexamethasone injections","volume":"29","author":"Hill","year":"2008","journal-title":"Otol. Neurotol."},{"issue":"1","key":"10.1016\/j.heares.2019.02.006_bib19","first-page":"115","article-title":"Dexamethasone otoprotection in multidose cisplatin ototoxicity mouse model","volume":"150","author":"Hughes","year":"2014","journal-title":"Otol. Neurotol."},{"key":"10.1016\/j.heares.2019.02.006_bib20","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s00405-006-0070-6","article-title":"Cisplatin ototoxicity and otoprotection with sodium salicylate","volume":"263","author":"Hyppolito","year":"2006","journal-title":"Eur. Arch. Oto-Rhino-Laryngol."},{"issue":"5","key":"10.1016\/j.heares.2019.02.006_bib21","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.4103\/0973-1482.188426","article-title":"Auditory function and quality of life in patients receiving cisplatin chemotherapy in head and neck caner: a case series follow-up study","volume":"14","author":"Kalyanam","year":"2018","journal-title":"J.\u00a0Canc. Res. Therapeut."},{"issue":"4","key":"10.1016\/j.heares.2019.02.006_bib22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1200\/JCO.2016.69.2319","article-title":"Group-wide, prospective study of ototoxciity assessment in children receiving cisplatin chemotherapy (ACCL05C1): a report from the Children's Oncology Group","volume":"35","author":"Knight","year":"2017","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"34","key":"10.1016\/j.heares.2019.02.006_bib23","doi-asserted-by":"crossref","first-page":"8588","DOI":"10.1200\/JCO.2004.00.5355","article-title":"Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development","volume":"23","author":"Knight","year":"2005","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"2","key":"10.1016\/j.heares.2019.02.006_bib24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/MPH.0b013e3181cb8593","article-title":"Late onset hearing loss: a significant complication of cancer survivors treated with cisplatin containing chemotherapy regimens","volume":"32","author":"Kollinsky","year":"2010","journal-title":"J.\u00a0Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.heares.2019.02.006_bib25","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1288\/00005537-198808000-00014","article-title":"Ototoxicity of high-dose cisplatin by bolus administration in patients with advanced cancers and normal hearing","volume":"98","author":"Kopelman","year":"1988","journal-title":"Laryngoscope"},{"key":"10.1016\/j.heares.2019.02.006_bib26","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1067\/mhn.2002.125299","article-title":"Round window application of D-methionine provides complete cisplatin otoprotection","volume":"126","author":"Korver","year":"2002","journal-title":"Otolaryngol. Head Neck Surg."},{"issue":"1-2","key":"10.1016\/j.heares.2019.02.006_bib62","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0378-5955(99)00090-8","article-title":"Vestibular responses to linear accelaration are absent in otoconia-deficient C57BL\/6JEi-het mice","volume":"135","author":"Jones","year":"1999","journal-title":"Hear Res."},{"issue":"1-2","key":"10.1016\/j.heares.2019.02.006_bib63","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.heares.2011.05.005","article-title":"The adequate stimulus for mammalian linear vestibular evoked potentials (VsEPs)","volume":"280","author":"Jones","year":"2011","journal-title":"Hear Res"},{"issue":"8","key":"10.1016\/j.heares.2019.02.006_bib27","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.tips.2013.05.006","article-title":"Understanding platinum-induced ototoxicity","volume":"34","author":"Langer","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.heares.2019.02.006_bib28","unstructured":"Lippman AJ, Helson C, Helson L, Krakoff IH. Clinical trials of cis-diamminedichloroplatinum (NSC-119875). Cancer Chemother Rep, 57: 191-200."},{"key":"10.1016\/j.heares.2019.02.006_bib29","article-title":"Wnt signaling activates TP53-induced glycolysis and apoptosis regulator and protects against cisplatin-induced spiral ganglion neuron damage in the mouse cochlea","author":"Liu","year":"2018","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.heares.2019.02.006_bib30","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00066-018-1347-6","article-title":"Age-corrected hearing loss after chemoradiation in cervical cancer patients","volume":"194","author":"Marnitz","year":"2018","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.heares.2019.02.006_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0378-5955(90)90151-E","article-title":"The ototoxic mechanism of cisplatin","volume":"47","author":"McAlpine","year":"1990","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2019.02.006_bib32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.heares.2004.07.016","article-title":"Antioxidant protection in a new animal model of cisplatin-induced ototoxicity","volume":"198","author":"Minami","year":"2004","journal-title":"Hear. Res."},{"issue":"2","key":"10.1016\/j.heares.2019.02.006_bib33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10162-010-0247-y","article-title":"Gravity receptor aging in the CBA\/CaJ strain: a comparison to auditory aging","volume":"12","author":"Mock","year":"2011","journal-title":"J\u00a0Assoc Res Otolaryngol"},{"key":"10.1016\/j.heares.2019.02.006_bib34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.heares.2004.08.011","article-title":"A\u00a0physiological place-frequency map of the cochlea in the CBA\/J mouse","volume":"202","author":"M\u00fcller","year":"2005","journal-title":"Hear. Res."},{"issue":"4","key":"10.1016\/j.heares.2019.02.006_bib35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/019459989310800403","article-title":"Is cis-platinum vestibulotoxic?","volume":"108","author":"Myers","year":"1993","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.heares.2019.02.006_bib36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijporl.2016.09.001","article-title":"Analysis of genetic and non genetic risk factors for cisplatin ototoxicity in pediatric patients","volume":"90","author":"Olgun","year":"2016","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"10.1016\/j.heares.2019.02.006_bib37","first-page":"61","article-title":"Very high-dose cisplatin-induced ototoxicity: a preliminary report on early and long-term effects","volume":"21","author":"Pollera","year":"1988","journal-title":"Cancer Chemther Pharmcol"},{"key":"10.1016\/j.heares.2019.02.006_bib38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.toxlet.2009.12.003","article-title":"Ototoxic drugs: difference in sensitivity between mice and Guinea pigs","volume":"193","author":"Poirrier","year":"2010","journal-title":"Toxicol. Lett."},{"issue":"6","key":"10.1016\/j.heares.2019.02.006_bib39","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1200\/JCO.2006.10.077","article-title":"Relationship between cisplatin administration and the development of ototoxicity","volume":"24","author":"Rademaker-Lakhai","year":"2006","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"1","key":"10.1016\/j.heares.2019.02.006_bib40","first-page":"19","article-title":"Ototoxicity in patients receiving cisplatin: importace of dose and method of administration","volume":"66","author":"Reddel","year":"1982","journal-title":"Cancer Treat Rep."},{"issue":"11","key":"10.1016\/j.heares.2019.02.006_bib41","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1172\/JCI71353","article-title":"Sound preconditioning therapy inhibits ototoxic hearing loss in mice","volume":"123","author":"Roy","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"issue":"5","key":"10.1016\/j.heares.2019.02.006_bib42","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/MOO.0b013e3282eee452","article-title":"Mechanisms of cisplatin ototoxicity and progress in otoprotection","volume":"15","author":"Rybak","year":"2007","journal-title":"Curr. Opin. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.heares.2019.02.006_bib44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.heares.2006.09.015","article-title":"Mechanisms of cisplatin-induced ototoxicity and prevention","volume":"226","author":"Rybak","year":"2007","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2019.02.006_bib45","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1177\/019459988609400410","article-title":"Ototoxicity of cisplatin vs platinum analogs CBDCA [JM-8] and CHIP [JM-9]","volume":"94","author":"Schweitzer","year":"1986","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.heares.2019.02.006_bib46","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0378-5955(03)00142-4","article-title":"Cisplatin ototoxicity in the Guinea pig: vestibular and cochlear damage","volume":"182","author":"Sergi","year":"2003","journal-title":"Hear. Res."},{"issue":"1\u20132","key":"10.1016\/j.heares.2019.02.006_bib47","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0378-5955(03)00260-0","article-title":"Alterations in the stria vascularis in relation to cisplatin ototoxicity and recovery","volume":"185","author":"Sluyter","year":"2003","journal-title":"Hear. Res."},{"issue":"3","key":"10.1016\/j.heares.2019.02.006_bib48","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s10162-008-0126-y","article-title":"Evidence that cisplatin-induced auditory damage is attenuated by downregulation of pro-inflammatory cytokines via Nrf2\/HO-1","volume":"9","author":"So","year":"2008","journal-title":"J\u00a0Assoc Res Otolaryngol"},{"key":"10.1016\/j.heares.2019.02.006_bib49","first-page":"521","article-title":"Effect of high-dose cisplatin on auditory brainstem responses and otoacoustic emissions in laboratory animals","volume":"21","author":"Sockalingam","year":"2000","journal-title":"Am. J. Otol."},{"issue":"3","key":"10.1016\/j.heares.2019.02.006_bib50","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1200\/JCO.2011.37.4025","article-title":"Impact of long-term serum platinum concentrations on neuro- and ototoxicity in cisplatin-treated survivors of testicular cancer","volume":"30","author":"Sprauten","year":"2012","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.heares.2019.02.006_bib51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.toxlet.2016.09.009","article-title":"Cisplatin-induced toxicity decreases the mouse vestibulo-ocular reflex","volume":"262","author":"Takimoto","year":"2016","journal-title":"Toxicology Letters"},{"issue":"1\u20132","key":"10.1016\/j.heares.2019.02.006_bib52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0378-5955(02)00771-2","article-title":"Influence of pH on the ototoxicity of cisplatin: a round window application study","volume":"177","author":"Tanaka","year":"2003","journal-title":"Hear. Res."},{"issue":"4","key":"10.1016\/j.heares.2019.02.006_bib53","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1084\/jem.20172246","article-title":"CDK2 inhibitors as candidate therapeutics for cisplatin- and noise-induced hearing loss","volume":"215","author":"Teitz","year":"2018","journal-title":"JEM"},{"issue":"3","key":"10.1016\/j.heares.2019.02.006_bib54","first-page":"319","article-title":"Body conditioning scoring: a rapid and accurate method for assessing health status of mice","volume":"49","author":"Ullman-Culler\u00e9","year":"1999","journal-title":"Lab. Anim. Sci."},{"issue":"7","key":"10.1016\/j.heares.2019.02.006_bib55","first-page":"CD009219","article-title":"Medical interventions for the prevention of platinum-induced hearing loss in children with cancer","author":"van As","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.heares.2019.02.006_bib56","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijporl.2018.01.028","article-title":"Long term platinum-induced ototoxicity in pediatric patients","volume":"107","author":"Waissbluth","year":"2018","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"issue":"2","key":"10.1016\/j.heares.2019.02.006_bib57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00003446-199104000-00003","article-title":"Ototoxicity due to Cis-diamminedichloro-platinum in the treatment of ovarian cancer: influence of dosage and schedule of administration","volume":"12","author":"Waters","year":"1991","journal-title":"Ear Hear."},{"key":"10.1016\/j.heares.2019.02.006_bib58","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.bcp.2004.01.010","article-title":"Protection against cisplatin ototoxicity by adenosine agonists","volume":"67","author":"Whitworth","year":"2004","journal-title":"Biochem. Pharmacol."},{"issue":"15","key":"10.1016\/j.heares.2019.02.006_bib59","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejphar.2017.02.052","article-title":"Allicin protects against cisplatin-induced vestibular dysfunction by inhibiting the apoptotic pathway","volume":"805","author":"Wu","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.heares.2019.02.006_bib60","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2131\/jts.37.823","article-title":"Ototoxicity of cisplatin administered to Guinea pigs via the round window membrane","volume":"37","author":"Xia","year":"2012","journal-title":"J.\u00a0Toxicol. Sci."},{"issue":"4","key":"10.1016\/j.heares.2019.02.006_bib61","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MPH.0000000000000028","article-title":"Cisplatin-induced hearing loss: the need for long-term evaluating system","volume":"36","author":"Yasui","year":"2014","journal-title":"J.\u00a0Pediatr. Hematol. Oncol."}],"container-title":["Hearing Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037859551930005X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037859551930005X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T12:44:38Z","timestamp":1565181878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037859551930005X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":62,"alternative-id":["S037859551930005X"],"URL":"https:\/\/doi.org\/10.1016\/j.heares.2019.02.006","relation":{},"ISSN":["0378-5955"],"issn-type":[{"value":"0378-5955","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity","name":"articletitle","label":"Article Title"},{"value":"Hearing Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heares.2019.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}